Why the world shouldn’t dismiss North Korea’s COVID-19 vaccine trials
North Korea's increased investment and emphasis on research means COVID-19 clinical trials might actually be underway
On July 18, North Korea announced that a domestically produced COVID-19 vaccine entered clinical trials, joining the global race to develop a cure for a virus that has already killed at least 650,000 people worldwide.
An otherwise quiet North Korean state website, Mirae, first published the report, which was then quickly picked up by South Korean media and even CNN. The New York Times went so far as to add the North Korean clinical trial to its vaccine tracker.
Nevertheless, news media was quick to stress doubt that the DPRK had the funds or expertise to develop
- 01North Korea may have continued Namibian Air Force job in violation of sanctions
- 02End of North Korean unification magazine another sign of friction on peninsula
- 03Layered cyber deterrence: A new US cyber strategy against North Korea
- 04FULL TEXT: North Korea’s Workers’ Party rule book
- 05Three years on, little for US and North Korea to build on from Singapore deal
- 06Everything you need to know about North Korea’s new Party rules
- 07Why new housing in Pyongyang is a survival strategy for Kim Jong Un
- 08How a North Korean ship changed hands multiple times in just over a decade